Stay updated on FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial
Sign up to get notified when there's something new on the FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial page.
Latest updates to the FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check19 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for those who can answer questions about joining the study, along with a reference to the Contacts and Locations section.SummaryDifference2%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe website has added new features while removing extensive options for downloading study data, including various file formats and detailed data fields.SummaryDifference3%
- Check41 days agoChange DetectedSeveral key medical and research resources related to soft tissue sarcoma and treatments like Trabectedin, Ipilimumab, and Nivolumab have been removed from the website.SummaryDifference0.5%
- Check48 days agoChange DetectedThe website has been updated to version 2.12.2, with new resources added including links to MedlinePlus, DailyMed, and PubMed, as well as additional data fields for study information.SummaryDifference4%
- Check56 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
Stay in the know with updates to FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial page.